research use only
Cat.No.P1220
Amino-acid Sequence
CAS No. 500992-11-0
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Storage (From the date of receipt) | 3 years-20°C powder | ||
|
In vitro |
DMSO
: 100 mg/mL
(39.7 mM);
Water : 100 mg/mL Ethanol : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Tat-NR2B9c (Tat-NR2Bct, NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively, and disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively, also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy. |
|---|
References |
|
| Molecular Formula | C105H188N42O30 |
|---|---|
| Molecular Weight | 2518.88 |
| CAS No. | 500992-11-0 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years-20°C powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |